Temozolomide

NDC 73043-012 · Devatis, Inc.

Generic nameTemozolomide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength20 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

73043-012-05 — 5 CAPSULE in 1 BOTTLE (73043-012-05)

73043-012-14 — 14 CAPSULE in 1 BOTTLE (73043-012-14)

FDA lists these products with the same active ingredient.

70301-2007 — TEMOZOLOMIDE, 70301-2009 — TEMOZOLOMIDE, 70301-2011 — TEMOZOLOMIDE, 72162-2659 — Temozolomide, 72162-2660 — Temozolomide, 72162-2661 — Temozolomide, 72162-2662 — Temozolomide, 72162-2663 — Temozolomide, 72162-2664 — Temozolomide, 73043-011 — Temozolomide, 73043-013 — Temozolomide, 73043-014 — Temozolomide, 73043-015 — Temozolomide, 73043-016 — Temozolomide, 75834-132 — temozolomide, 75834-142 — temozolomide, 75834-143 — temozolomide, 75834-144 — temozolomide, 75834-145 — temozolomide, 75834-146 — temozolomide, +50 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.